Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company’s products portfolio includes SARS-CoV/CoV-2 DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company provides integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services. It serves academic, research institutions, and pharmaceutical factories. The company was founded in 2002 and is headquartered in Taipei, Taiwan.
तुलना करने के लिए मीट्रिक्स | 4133 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध4133पीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 783.8x | 28.7x | −0.6x | |
PEG अनुपात | −8.09 | −0.76 | 0.00 | |
क़ीमत/बुक | 1.1x | 3.4x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 4.0x | 4.8x | 3.4x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 36.3% | 41.3% | |
उचित मूल्य अपसाइड | अनलॉक करें | 5.3% | 4.9% | अनलॉक करें |